Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,035 total articles

NexPoint Residential CIO Increases Stake With $48,740 Purchase

NexPoint Residential CIO Increases Stake With $48,740 Purchase

NexPoint Residential Trust Executive Vice President and Chief Investment Officer Matt McGraner purchased 2,000 shares on March 20, 2026, for $24.37 each, a $48,740 transaction. The buy comes while the stock trades close to its 52-week low and after the company reported a Q4 2025 net loss and slight revenue shortfall. Analysts have reacted with adju…

Exzeo Director Adds 4,000 Shares as Company Posts Q4 and Full-Year 2025 Results In Line With Forecasts

Exzeo Director Adds 4,000 Shares as Company Posts Q4 and Full-Year 2025 Results In Line With Forecasts

Exzeo Group Director James J. Macchiarola bought 4,000 shares on March 23, 2026 at $15.12 per share, a $60,480 transaction that brings his direct holdings to 140,000 shares. Separately, Exzeo reported fourth-quarter and full-year 2025 results that matched earnings expectations, recording diluted EPS of $0.25 and quarterly revenue of $53.32 million.…

United Therapeutics CEO Sells 9,500 Shares Following Option Exercise; Company Advances $2B Buyback and Positive Trial News

United Therapeutics CEO Sells 9,500 Shares Following Option Exercise; Company Advances $2B Buyback and Positive Trial News

Martine Rothblatt, chairperson and CEO of United Therapeutics (UTHR), sold 9,500 shares on March 23, 2026, after exercising options. The transactions, completed under a 10b5-1 trading plan, generated roughly $5 million. The moves occur alongside a $2 billion share repurchase program, analyst price-target actions, and published positive phase 3 data…

Robinhood CTO Executes $416K Sale of Class A Shares

Robinhood CTO Executes $416K Sale of Class A Shares

Robinhood Markets Chief Technology Officer Jeffrey Tsvi Pinner sold 5,835 shares of Class A common stock on March 20, 2026, for about $416,392 across four transactions executed under a Rule 10b5-1 plan. The trades were carried out at prices between $70.5483 and $73.28. After the disposition, Pinner directly holds 23,841 Class A shares. The sale occ…

Sono-Tek Director Increases Stake with $9,888 Purchase as Company Secures Medical Order and New Collaboration

Sono-Tek Director Increases Stake with $9,888 Purchase as Company Secures Medical Order and New Collaboration

Lawal Adeniyi, a director of Sono-Tek CORP (NASDAQ: SOTK), acquired 2,400 common shares for $9,888 on March 5, 2026, at $4.12 per share, increasing his direct ownership according to a Form 4 filing. The transaction occurred above the company’s prevailing market price of $3.98. Separately, Sono-Tek disclosed an $820,000 purchase order for coating eq…

Stoke Therapeutics General Counsel Disposes of $313k in Stock as Analysts Raise Stakes on Lead Drug

Stoke Therapeutics General Counsel Disposes of $313k in Stock as Analysts Raise Stakes on Lead Drug

Jonathan Allan, general counsel and corporate secretary of Stoke Therapeutics (STOK), sold 9,293 shares on March 20, 2026 under a pre-arranged 10b5-1 plan, netting $313,038. The insider still holds 19,543 shares. The sale comes amid strong share price performance, analyst upgrades and initiation of coverage, and a board-approved discretionary bonus…